CD47 and neoplasm: These data suggest that NP/R848/siCD47 may hold great potential in tumor immunotherapy by inhibiting the expression of CD47 gene in tumor cells so as to reduce tumor immune evasion while activating APCs and contributing to tumor suppression in vivo.